These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 6200559)

  • 1. Hepatitis B surface antigen and alpha-1-fetoprotein in hepatoma. Reports of 157 cases.
    Pongpipat D; Suvatte V; Plengvanit U; Chinapak O; Bunyaphisit S; Assateerawatts A
    J Med Assoc Thai; 1983 Nov; 66(11):696-9. PubMed ID: 6200559
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevalence of hepatitis B virus and primary hepatocellular carcinoma in Asia.
    Obata H; Nishioka K
    Southeast Asian J Trop Med Public Health; 1979 Dec; 10(4):621-6. PubMed ID: 94184
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunohistochemistry of hepatocellular carcinoma associated with cirrhosis.
    Espinoza CG; Pillarisetti SG; Azar HA
    Ann Clin Lab Sci; 1984; 14(6):467-73. PubMed ID: 6210034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunologic and immuno-histochemical determination of alpha l-fetoprotein and HBs antigens in hepatocellular carcinoma].
    Perisić-Savić M; Perisić V; Sinćić M; Janev A; Nastić-Mirić D
    Srp Arh Celok Lek; 1981; 109(5-6):775-82. PubMed ID: 6179170
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatitis B surface antigen and alpha-fetoprotein in patients with hepatocellular carcinoma.
    Chen DS; Sung FL
    Gastroenterology; 1978 Jan; 74(1):163-4. PubMed ID: 72701
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatitis B antigen and alpha fetoprotein in the sera of patients with hepatocellular carcinoma.
    Rajagopalan N; Sama SK; Krishnamurthy L; Gandhi G; Nayak NC
    Indian J Med Res; 1977 Jan; 65(1):95-100. PubMed ID: 68001
    [No Abstract]   [Full Text] [Related]  

  • 7. Primary hepatocellular carcinoma with hepatitis B virus infection in a 16-year-old noncirrhotic patient.
    Gasser RW; Judmaier G; Zur Nedden D; Aufschnaiter M; Hofstaedter F
    Am J Gastroenterol; 1983 May; 78(5):305-8. PubMed ID: 6189392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B antigen, alpha-fetoglobulins and primary hepatocellular carcinoma in Ethiopia.
    Tsega E; Gold P; Shuster J; Whittemore B; Lester FT
    J Trop Med Hyg; 1976 Oct; 79(10):230-4. PubMed ID: 64619
    [No Abstract]   [Full Text] [Related]  

  • 9. A study of hepatitis Bs antigen titres and alpha foetoprotein levels in primary hepatocellular carcinoma in Kenya.
    Bowry TR; Shah MV
    East Afr Med J; 1980 Jun; 57(6):382--9. PubMed ID: 6156817
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatitis B surface antigenemia in patients with hepatocellular carcinoma in relation to clinical course and alpha-fetoprotein.
    Kubo Y; Okuda K; Shimokawa Y; Arishima T; Nagata E
    Gastroenterology; 1977 Jun; 72(6):1213-6. PubMed ID: 67061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum alpha-fetoprotein and hepatitis B antigen in subjects with hepatoma in south India.
    Hill PG; Johnson S; Madanagopalan N
    Indian J Med Res; 1977 Apr; 65(4):482-7. PubMed ID: 71266
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevalence of hepatitis B viral markers in hepatitis B endemic areas of China.
    Luo S; Ye FS; Mo ZC; Su YX; He JS; Zhou CQ; Tong MJ; Henderson BE; Yu MC
    Chin Med J (Engl); 1988 Sep; 101(9):654-8. PubMed ID: 2466618
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinicopathological features of hepatocellular carcinoma--comparison of hepatitis B seropositive and seronegative patients.
    Okuda H; Obata H; Motoike Y; Hisamitsu T
    Hepatogastroenterology; 1984 Apr; 31(2):64-8. PubMed ID: 6202615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serum alpha-fetoprotein and hepatitis B surface antigen in patients with hepatocellular carcinoma (author's transl)].
    Kao MC; Yin SJ; Lee SC; Lin CY; Cheng TC; Fong MS
    Taiwan Yi Xue Hui Za Zhi; 1980 Nov; 79(11):1032-7. PubMed ID: 6166727
    [No Abstract]   [Full Text] [Related]  

  • 15. Recognition of hepatitis B surface antigen by the human hepatoma cell line HepG2.
    Kaiser J; Stockert RJ; Schein PS; Wolkoff AW
    Trans Assoc Am Physicians; 1986; 99():86-91. PubMed ID: 3037754
    [No Abstract]   [Full Text] [Related]  

  • 16. Lack of leukocyte migration inhibition by hepatitis B surface antigen in hepatocellular carcinoma patients.
    Lee CS; Chang KJ; Chen DS; Lin TY
    Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1979 Sep; 12(3):86-92. PubMed ID: 94850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alphafetoprotein levels measured by radioimmunoassay in various liver malignancies.
    Chang FY; Chen TC; Fong MS; Lin S; Yeh SH
    Taiwan Yi Xue Hui Za Zhi; 1982 Feb; 81(2):224-31. PubMed ID: 6178794
    [No Abstract]   [Full Text] [Related]  

  • 18. [Serum hepatitis B antigen-antibody system in patients with hepatocellular carcinoma].
    Wu A; Cheng G
    Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):441-3. PubMed ID: 8697998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation "hot spot" in HLA class I-restricted T cell epitope on hepatitis B surface antigen in chronic carriers and hepatocellular carcinoma.
    Chen WN; Oon CJ
    Biochem Biophys Res Commun; 1999 Sep; 262(3):757-61. PubMed ID: 10471398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatitis B antigen in the serum in chronic liver diseases and malignant hepatoma].
    Libman E; Stojsić S; Marton B; Lemberger J
    Med Pregl; 1981; 34(9-10):389-92. PubMed ID: 6281636
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.